Biomarkers

Blood#

Blood lead level (BLL): Standard for lead (Pb) exposure; reflects recent/ongoing exposure (half-life ~30 days in blood). No safe threshold established. Blood mercury (Hg): Total and speciated (methyl vs. inorganic); reflects recent fish consumption and chronic exposure.

Serum zinc (Zn), copper (Cu), iron (Fe): Reflect circulating levels but are confounded by Metal-Driven Inflammation (acute-phase responses alter copper and iron distribution). Ceruloplasmin: Copper-containing acute-phase protein; elevated in inflammation, low in Wilson's disease.

Urine#

Urinary cadmium (Cd): Reflects long-term body burden (renal accumulation); beta-2 microglobulin co-measurement indicates tubular damage.^{[1]Toxic Mechanisms of Five Heavy Metals: Mercury, Lead, Chromium, Cadmium, and ArsenicBalali-Mood M, Naseri K, Tahergorabi Z et al. · 2021Open reference 1 ↓} Urinary As: Speciation (inorganic vs. organic) distinguishes toxic exposure from dietary arsenobetaine (seafood). 8-OHdG: Urinary oxidative DNA damage marker; elevated with arsenic (As), chromium (Cr), cadmium exposure.

Metallophores: Emerging—microbial siderophores detectable in urine as infection biomarkers.^{[2]Infection metallomics for critical care in the post-COVID eraPatil RH, Luptakova D, Havlicek V · 2021Open reference 2 ↓}

Hair and Toenails#

Hair metals: Reflect months of exposure; used in epidemiological studies of mercury (Hg) (from fish), arsenic (As), and lead (Pb). Subject to external contamination. Toenail metals: Integrate 6-12 months of exposure; less prone to external contamination than hair; used for selenium (Se), arsenic, mercury assessment.

Tissue#

Liver iron (Fe) (ferritin, MRI): Gold standard for iron overload assessment. Bone lead (Pb): K-XRF measurement reflects cumulative lifetime lead exposure (half-life ~20-30 years in bone).

Microbiome Biomarkers#

See Microbial Biomarkers for detailed treatment. Key examples. F. prausnitzii depletion: IBD diagnostic and relapse predictor.

F. nucleatum enrichment: CRC diagnostic and prognostic marker. Alpha diversity reduction: Non-specific but consistent marker of Dysbiosis across metal exposure and disease states.

Metabolite Biomarkers#

Trimethylamine N-Oxide (TMAO): Plasma levels predict cardiovascular events; reflects gut microbial choline/carnitine metabolism. p-Cresol sulfate: Elevated in ASD and CKD; reflects Clostridioides activity in gut. Calprotectin (S100A8/A9) (fecal): Neutrophil-derived; gold standard for non-invasive IBD monitoring.

Hepcidin: Circulating peptide reflecting iron status and inflammatory state; low in iron deficiency, high in inflammation. Fecal SCFAs: Reduced Butyrate/propionate reflects loss of fermentative microbiome capacity. Indoxyl sulfate: Uremic toxin; microbial indole derivative accumulating in CKD.

Challenges#

Specimen timing: Blood reflects acute exposure; urine reflects recent clearance; hair/nails reflect chronic burden. No single specimen captures the full picture. Confounders: Inflammation alters metal distribution (hypoferremia, hypercupremia of infection); dietary intake affects both metal and microbiome markers.

Reference ranges: Vary by population, age, sex, and analytical method; no universal thresholds for most metals.